4//SEC Filing
Eggenberg Michael 4
Accession 0001235802-20-000046
CIK 0001453593other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:59 PM ET
Size
10.4 KB
Accession
0001235802-20-000046
Insider Transaction Report
Form 4
Eggenberg Michael
Director10% Owner
Transactions
- Award
Warrant (right to buy)
2020-05-06+1,531,984→ 1,531,984 total(indirect: See footnotes)Exercise: $0.01From: 2020-11-06Exp: 2030-05-06→ Common Stock (1,531,984 underlying) - Award
Warrant (right to buy)
2020-05-06+868,016→ 868,016 total(indirect: See footnotes)Exercise: $0.01From: 2020-11-06Exp: 2030-05-06→ Common Stock (868,016 underlying)
Footnotes (5)
- [F1]This warrant was issued by Xtant Medical Holdings, Inc. in connection with that certain First Amendment to Second Amended and Restated Credit Agreement, effective as of April 1, 2020.
- [F2]Only represents derivative securities of this class.
- [F3]These securities are held of record by ROS Acquisition Offshore LP ("ROS Acquisition"). OrbiMed Advisors LLC ("Advisors"), a registered investment adviser under the Investment Advisors Act of 1940, as amended, is the investment manager of ROS Acquisition. Advisors is also the investment manager of Royalty Opportunities S.a r.l., of which ROS Acquisition is a wholly-owned subsidiary. By virtue of such relationships, Advisors may be deemed to have voting and investment power with respect to the securities held by ROS Acquisition noted above and as a result may be deemed to have beneficial ownership over such securities. Advisors exercises its investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the securities held by ROS Acquisition.
- [F4]Each of ROS Acquisition, OrbiMed Royalty Opportunities II, LP ("ORO II"), Advisors and the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act, or for any other purposes. The Reporting Person is an employee of Advisors.
- [F5]These securities are held of record by ORO II. OrbiMed ROF II LLC ("ROF II") is the general partner of ORO II, and Advisors is the managing member of ROF II. By virtue of such relationships, Advisors may be deemed to have voting and investment power with respect to the securities held by ORO II noted above and as a result may be deemed to have beneficial ownership over such securities. Advisors exercises its investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the securities held by ORO II.
Documents
Issuer
Xtant Medical Holdings, Inc.
CIK 0001453593
Entity typeother
Related Parties
1- filerCIK 0001732521
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 4:59 PM ET
- Size
- 10.4 KB